Total Nutraceutical (ERGO) 0.2350 $ERGO
Entia Biosciences CEO and SAB Member Invited to Chair Sessions and Speak at 17th International Functional Food Conference
ACCESSWIRE - Fri Nov 14, 9:15AM CST
SHERWOOD, OR / ACCESSWIRE / November 14, 2014 / Entia Biosciences Inc. (OTCQB: ERGO), an emerging leader in the field of nutrigenomics, announces that Marvin S. Hausman MD, CEO, will speak on the subject - "Treatment of Anemia with a Natural Mushroom-Based Medical Food ErgoD2." The 17th International Conference of FFC, Discovery, Utilization, and Control of Bioactive Components and Functional Foods, November 18-19, 2014, will be held at the University of San Diego, San Diego, California, USA.
Entia Biosciences Announces Ergothioneine Study Results
ACCESSWIRE - Tue Sep 30, 9:16AM CDT
SHERWOOD, OR / ACCESSWIRE / September 30, 2014 / Entia Biosciences, Inc. (OTCQB: ERGO), an emerging leader in the field of nutrigenomics, today announced the publication of a study demonstrating the antioxidant and cytoprotective effects of Ergothioneine. The study, titled Uptake and Protective Effects of Ergothioneine in Human Endothelial Cells*, was published in the September 2014 issue of The Journal of Pharmacology and Experimental Therapeutics.
Entia Enhances GROH? Reach with Starzz Distribution Agreement
ACCESSWIRE - Mon Sep 29, 1:23PM CDT
Image: https://www.baystreet.ca/uploads/KDOYD9O0v.png
Entia Biosciences Inks Major Distribution Agreement for its GROH(R) Brand of Beauty & Wellness Products
ACCESSWIRE - Wed Sep 10, 9:50AM CDT
SHERWOOD, OR / ACCESSWIRE / September 10, 2014 / Entia Biosciences, Inc. (OTCQB: ERGO), an emerging leader in the field of nutrigenomics, today announced that it entered into an agreement with Shooting Starzz LLC Distribution Services on September 9th, 2014 to represent the GROH(R) product line in over 24,000 salons in nine states. The GROH(R) Ergo Boost product line leverages powerful antioxidants to promote thicker, stronger hair and lashes, healthier skin, and increased nail strength, as shown in a recent research study.
Entia Biosciences Inks Major Distribution Agreement for its GROH Brand of Beauty & Wellness Products
eTeligis - Wed Sep 10, 9:38AM CDT
SHERWOOD, OR, United States, via ETELIGIS INC., 09/10/2014 - - Entia Biosciences, Inc. (OTCQB: ERGO), an emerging leader in the field of nutrigenomics, today announced that it entered into an agreement with Shooting Starzz LLC Distribution Services on September 9th, 2014 to represent the GROH(R) product line in over 24,000 salons in nine states. The GROH(R) Ergo Boost product line leverages powerful antioxidants to promote thicker, stronger hair and lashes, healthier skin, and increased nail strength, as shown in a recent research study.
Entia Biosciences' Supplements Could Prevent Dementia
ACCESSWIRE - Tue Aug 12, 8:55AM CDT
WHITEFISH, MT / ACCESSWIRE / August 12, 2014 / Vitamin D deficiency has been associated with a number of conditions, ranging from cardiovascular disease to certain types of cancers, according to WebMD. On the other side of the coin, research suggests that vitamin D could play a role in the prevention and treatment of diabetes, hypertension, glucose intolerance, multiple sclerosis, and a number of other serious medical conditions.
JNJ: 103.42 (+1.12), PFE: 33.98 (-0.01), LLY: 72.94 (+0.04)
Entia Biosciences: Beauty From Within
ACCESSWIRE - Tue Jul 22, 9:01AM CDT
Entia Biosciences: Beauty Begins from Within
REV: 36.71 (+0.60), AVP: 7.18 (+0.22)
Entia Biosciences Secures Michael J. Fox Foundation Grant
Marketwire - Mon Jul 14, 9:15AM CDT
Entia Biosciences Inc. (OTCQB: ERGO), an emerging leader in the field of nutrigenomics, has been awarded a grant by The Michael J. Fox Foundation for Parkinson's Research to conduct a preclinical study of its ErgoD2(R) medical food formulation as a potential therapy for Parkinson's disease (PD). This study is the second and final in a series of planned studies conducted by Entia utilizing a transgenic murine model developed by Dr. Robert Nussbaum. The first study was successfully conducted in collaboration with Dr. Jack Rogers, PhD, at the Massachusetts General Hospital Neurochemistry Laboratory, in which ErgoD2(R) was shown to increase muscle strength and reduce the toxic buildup of midbrain alpha-synuclein levels. The newly commissioned study has been expanded to measure brain iron levels, key brain biomarkers, as well as, alpha-synuclein levels -- an approach that aims to provide insight into the overall physiologic system of the disease, which may prove invaluable in further substantiating ErgoD2's future role in the treatment and/or prevention of PD.
GROH(R) Exclusive Lifestyle & Wellness Category Sponsor of the International Battle of the Strands Competition
Marketwire - Fri Jul 11, 12:36PM CDT
Entia Biosciences, Inc. (OTCQB: ERGO) is excited to announce that its GROH brand will be an official sponsor of the 4th Annual, Battle of the Strands competition. The Battle of the Strands ("BOTS"
is an International Beauty Competition, reaching 10,000+ professional stylists, trainers & salon owners. Teams compete to be chosen as the top salon with the final competition airing on Discovery Channel in December 2014. The BOTS platform provides GROH with an incredible opportunity to support the industry's brightest stars and educate thousands of professionals on GROH's next generation of skin care and hair care technology.
Entia Biosciences CEO and SAB Member Invited to Chair Sessions and Speak at 17th International Functional Food Conference
ACCESSWIRE - Fri Nov 14, 9:15AM CST
SHERWOOD, OR / ACCESSWIRE / November 14, 2014 / Entia Biosciences Inc. (OTCQB: ERGO), an emerging leader in the field of nutrigenomics, announces that Marvin S. Hausman MD, CEO, will speak on the subject - "Treatment of Anemia with a Natural Mushroom-Based Medical Food ErgoD2." The 17th International Conference of FFC, Discovery, Utilization, and Control of Bioactive Components and Functional Foods, November 18-19, 2014, will be held at the University of San Diego, San Diego, California, USA.
Entia Biosciences Announces Ergothioneine Study Results
ACCESSWIRE - Tue Sep 30, 9:16AM CDT
SHERWOOD, OR / ACCESSWIRE / September 30, 2014 / Entia Biosciences, Inc. (OTCQB: ERGO), an emerging leader in the field of nutrigenomics, today announced the publication of a study demonstrating the antioxidant and cytoprotective effects of Ergothioneine. The study, titled Uptake and Protective Effects of Ergothioneine in Human Endothelial Cells*, was published in the September 2014 issue of The Journal of Pharmacology and Experimental Therapeutics.
Entia Enhances GROH? Reach with Starzz Distribution Agreement
ACCESSWIRE - Mon Sep 29, 1:23PM CDT
Image: https://www.baystreet.ca/uploads/KDOYD9O0v.png
Entia Biosciences Inks Major Distribution Agreement for its GROH(R) Brand of Beauty & Wellness Products
ACCESSWIRE - Wed Sep 10, 9:50AM CDT
SHERWOOD, OR / ACCESSWIRE / September 10, 2014 / Entia Biosciences, Inc. (OTCQB: ERGO), an emerging leader in the field of nutrigenomics, today announced that it entered into an agreement with Shooting Starzz LLC Distribution Services on September 9th, 2014 to represent the GROH(R) product line in over 24,000 salons in nine states. The GROH(R) Ergo Boost product line leverages powerful antioxidants to promote thicker, stronger hair and lashes, healthier skin, and increased nail strength, as shown in a recent research study.
Entia Biosciences Inks Major Distribution Agreement for its GROH Brand of Beauty & Wellness Products
eTeligis - Wed Sep 10, 9:38AM CDT
SHERWOOD, OR, United States, via ETELIGIS INC., 09/10/2014 - - Entia Biosciences, Inc. (OTCQB: ERGO), an emerging leader in the field of nutrigenomics, today announced that it entered into an agreement with Shooting Starzz LLC Distribution Services on September 9th, 2014 to represent the GROH(R) product line in over 24,000 salons in nine states. The GROH(R) Ergo Boost product line leverages powerful antioxidants to promote thicker, stronger hair and lashes, healthier skin, and increased nail strength, as shown in a recent research study.
Entia Biosciences' Supplements Could Prevent Dementia
ACCESSWIRE - Tue Aug 12, 8:55AM CDT
WHITEFISH, MT / ACCESSWIRE / August 12, 2014 / Vitamin D deficiency has been associated with a number of conditions, ranging from cardiovascular disease to certain types of cancers, according to WebMD. On the other side of the coin, research suggests that vitamin D could play a role in the prevention and treatment of diabetes, hypertension, glucose intolerance, multiple sclerosis, and a number of other serious medical conditions.
JNJ: 103.42 (+1.12), PFE: 33.98 (-0.01), LLY: 72.94 (+0.04)
Entia Biosciences: Beauty From Within
ACCESSWIRE - Tue Jul 22, 9:01AM CDT
Entia Biosciences: Beauty Begins from Within
REV: 36.71 (+0.60), AVP: 7.18 (+0.22)
Entia Biosciences Secures Michael J. Fox Foundation Grant
Marketwire - Mon Jul 14, 9:15AM CDT
Entia Biosciences Inc. (OTCQB: ERGO), an emerging leader in the field of nutrigenomics, has been awarded a grant by The Michael J. Fox Foundation for Parkinson's Research to conduct a preclinical study of its ErgoD2(R) medical food formulation as a potential therapy for Parkinson's disease (PD). This study is the second and final in a series of planned studies conducted by Entia utilizing a transgenic murine model developed by Dr. Robert Nussbaum. The first study was successfully conducted in collaboration with Dr. Jack Rogers, PhD, at the Massachusetts General Hospital Neurochemistry Laboratory, in which ErgoD2(R) was shown to increase muscle strength and reduce the toxic buildup of midbrain alpha-synuclein levels. The newly commissioned study has been expanded to measure brain iron levels, key brain biomarkers, as well as, alpha-synuclein levels -- an approach that aims to provide insight into the overall physiologic system of the disease, which may prove invaluable in further substantiating ErgoD2's future role in the treatment and/or prevention of PD.
GROH(R) Exclusive Lifestyle & Wellness Category Sponsor of the International Battle of the Strands Competition
Marketwire - Fri Jul 11, 12:36PM CDT
Entia Biosciences, Inc. (OTCQB: ERGO) is excited to announce that its GROH brand will be an official sponsor of the 4th Annual, Battle of the Strands competition. The Battle of the Strands ("BOTS"
is an International Beauty Competition, reaching 10,000+ professional stylists, trainers & salon owners. Teams compete to be chosen as the top salon with the final competition airing on Discovery Channel in December 2014. The BOTS platform provides GROH with an incredible opportunity to support the industry's brightest stars and educate thousands of professionals on GROH's next generation of skin care and hair care technology. 
